CRP and tuberculosis: In the subgroup analyses, patients whose CRP levels reduced <2 times (Group C) had similar anti-TB drug plasma exposure compared to those belonging to Groups A and B. Thus, in our setting, the variations in anti-TB drug plasma exposure did not result in clinically relevant consequences, although a long-term effect cannot be ruled out.